Use of serum biomarkers to predict cerebral hypoxia after severe traumatic brain injury

Journal of Neurotrauma

Volumn 29, Issue 6, 2012, Pages 1140-1149

  Stein, Deborah M ^a   Lindell, Allison L ^a   Murdock, Karen R ^a   Kufera, Joseph A ^a   Menaker, Jay ^a   Bochicchio, Grant V ^a   Aarabi, Bizhan ^a   Scalea, Thomas M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

biomarkers; clinical management of CNS injury; traumatic brain injury

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; NEURON SPECIFIC ENOLASE; PROTEIN S100B;

ADULT; ARTICLE; BRAIN HYPOXIA; BRAIN OXYGEN TENSION; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; SENSITIVITY AND SPECIFICITY; TRAUMATIC BRAIN INJURY;

ADULT; BIOLOGICAL MARKERS; BRAIN INJURIES; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; HYPOXIA, BRAIN; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; PHOSPHOPYRUVATE HYDRATASE; ROC CURVE; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84859899590     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2011.2149     Document Type: Article

References (39)

1. Aarabi, B., Hesdorffer, D.C., Ahn, E.S., Aresco, C., Scalea, T.M., and Eisenberg, H.M. (2006). Outcome following decompressive craniectomy for malignant swelling due to severe head injury. J. Neurosurg. 104, 469-479.
2. Aarabi, B., Hesdorffer, D.C., Simard, J.M., Ahn, E.S., Aresco, C., Eisenberg, H.M., McCunn, M., and Scalea, T. (2009). Comparative study of decompressive craniectomy after mass lesion evacuation in severe head injury. Neurosurgery 64, 927-939.
3. Association for the Advancement of Automotive Medicine. Abbreviated Injury Scale, 2005. Barrington, IL.
4. Astudillo, R., van der Linden, J., Radegran, K., Hanson, L.O., and Aberg, B. (1996). Elevated serum levels of S-100 after deep hypothermic arrest correlate with duration of circulatory arrest. Eur. J. Cardiothoracic Surg. 10, 1107-1112; discussion 1113.
5. Bardt, T.F., Unterberg, A.W., Hertl, R., Kiening, K.L., Schneider, G.H., and Lanksch, W.R. (1998). Monitoring of brain tissue PO2 in traumatic brain injury: effect of cerebral hypoxia on outcome. Acta Neurochir. 71, 153-156. (Pubitemid 128444384)
6. Basile, A.M., Fusi, C., Conti, A.B., Paniccia, R., Trefoloni, G., Pracucci, G., DiCarlo, A., Norferi, D., Carbonetto, F., Pretelli, P., Calamai, G., Vaccari, M., Abbate, R., and Inzitari. D. (2001). S-100 protein and neuron-specific enolase as markers of subclinical cerebral damage after cardiac surgery: preliminary observation of a 6-moth follow-up study. Eur. Neurol. 45, 151-159. (Pubitemid 32304693)
7. Berger, R.P., Adelson, P.D., Richichi, R., and Kochanek, P.M. (2006). Serum biomarkers after traumatic and hypoxemic brain injuries: insight into the biochemical response of the pediatric brain to inflicted brain injury. Dev. Neurosci. 28, 327-335. (Pubitemid 44310498)
8. Berger, R.P., Beers, S.R., Richichi, R., Wiesman, D., and Adelson, P.D. (2007). Serum biomarker concentrations and outcome after pediatric traumatic brain injury. J. Neurotrauma 24, 1793-1801.
9. Berger, R.P., Pierce, M.C., Wisniewski, S.R., Adelson, P.D., Clark, R.S., Ruppel, R.A., and Kochanek, P.M. (2002). Neuron specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics 109, E31.
10. Blyth, B.J., Farhavar, A., Gee, C., Hawthorn, B., He, H., Nayak, A., Stocklein, V., and Bazarian, J.J. (2009). Validation of serum markers for blood-brain barrier disruption in traumatic brain injury. J. Neurotrauma 26, 1497-1507.
11. Böhmer, A.E., Oses, J.P., Schmidt, A.P., Peron, C.S., Krebs, C.L., Oppitz, P.P., D'Avila, T.T., Souza, D.O., Portela, L.V., and Stefani, M.A. (2011). NSE, S100B and GFAP levels as outcome predictors in patients with severe traumatic brain injury. Neurosurgery 68, 1624-1631.
12. Boyd, C.R., Tolson, M.A., and Copes, W.S. (1987). Evaluating trauma care: the TRISS method. Trauma Score and the Injury Severity Score. J. Trauma 27, 370-378.
13. Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma and Critical Care. AANS/CNS. (2007). Guidelines for the management of severe traumatic brain injury. J. Neurotrauma 24(Suppl. 1), S37-S44.
14. Bridges, E., and Biever, K. (2010). Joint Combat Casualty Research Team and Joint Theater Trauma System. AACN Advanced Critical Care 21, 260-276.
15. Chambers, I.R., Treadwell, L., and Mendelow, A.D. (2000). The cause and incidence of secondary insults in severely headinjured adults and children. Br. J. Neurosurg. 14, 424-431.
16. Cunningham, R.T., Watt, M., Winder, J., McKinstry, S., Lawson, J.T., Johnston, C.F., Hawkins, S.A., and Buchanan, K.D. (1996). Serum neurone-specific enolase as an indicator of stroke volume. Eur. J. Clin. Invest. 26, 298-303. (Pubitemid 26147065)
17. Cunningham, R.T., Young, I.S., Winder, J., O'Kane, M.I., McKinstry, S., Johnston, C.F., Dolan, O.M., Hawkins, S.A., and Buchanan, K.D. (1991). Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction. Eur. J. Clin. Invest. 21, 497-500.
18. Dauberschmidt, R., Zinsmeyer, J., Mrochen, H., and Meyer, M. (1991). Changes in neuron-specific enolase concentration in plasma after cardiac arrest and resuscitation. Mol. Chem. Neuropathol. 14, 237-245.
19. Dings, J., Jager, A., Meixensberger, J., and Roosen, K. (1998). Brain tissue PO2 and outcome after severe head injury. Neurol. Res. Suppl. 1, S71-S75. (Pubitemid 28223674)
20. Elting, J.W., deJager, A.E.J., Teelken, A.W., Schaaf, M.J., Maurits, N.M., van der Nault, J., Sibinga, C.T.S., Sulter, G.A., and de- Keyser, J. (2000). Comparison of serum S-100 protein levels following stroke and traumatic brain injury. J. Neurolog. Sci. 181, 104-110.
21. Figaji, A.A., Zwane, E., Thompson, C., Fieggen, A.G., Argent, A.C., LeRoux, P.D., and Peter, J.C. (2009). Brain tissue oxygen tension monitoring in pediatric severe traumatic brain injury. Childs Nerv. Syst. 25, 1335-1343.
22. Ghajar, J. (2000). Traumatic brain injury. Lancet 356, 923-929.
23. Goodman, M.D., Makley, A.T., Lentsch, A.B., Barnes, S.L., Dorlac, G.R., Dorlac, W.C., Johannigman, J.A., and Pritts, T.A. (2010). Traumatic brain injury and aeromedical evacuation: When is the brain fit to fly? J. Surg. Res. 164, 286-293.
24. Gracias, V.H., Guillamondegui, O.D., Stiefel, M.F., Wilensky, E.M., Bloom, S., Gupta, R., Pryor, J.P., Reilly, P.M., Leroux, P.D., and Schwab, C.W. (2004). Cerebral cortical oxygenation: a pilot study. J. Trauma 56, 469-474. (Pubitemid 38523694)
25. Graham, D.I., Adams, J.H., and Doyle, D. (1978). Ischemic brain damage in fatal non-missile head injuries. J. Neurol. Sci. 39, 213-234. (Pubitemid 9030533)
26. Hayakata, T., Shiozaki, T., Tasaki, O., Ikegawa, H., Inoue, Y., Toshiyuki, F., Hosotubo, H., Kieko, F., Yamashita, T., Tanaka, H., Shimazu, T., and Sugimoto, H. (2004). Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury. Shock 22, 102-107. (Pubitemid 40228186)
27. Honda, M., Tsuruta, R., Kaneko, T., Kasaoka, S., Yagi, T., Todani, M., Fujita, M., Izumi, T., and Maekawa, T. (2010). Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase. J. Trauma 69, 104-109.
28. Joseph, D.K., Dutton, R.P., Aarabi, B., and Scalea, T.M. (2004). Decompressive laparotomy to treat intractable intracranial hypertension after traumatic brain injury. J. Trauma 57, 687- 693; discussion 693-695.
29. Kahraman, S., Hu, P., Xiao, Y., Dutton, R.P., Aarabi, B., Stein, D.M., and Scalea, T.M. (2010). Pressure-time dose of automated ICP and CPP data predicts outcomes in severe TBI. J. Trauma 69, 110-118.
30. Kelly, J.F., Ritenour, A.E., McLaughlin, D.F., Bagg, K.A., Apodaca, A.N., Mallak, C.T., Pearse, L., Lawnick, M.M., Champion, H.R., Wade, C.E., and Holcomb, J.B. (2008). Injury severity and causes of death from Operation Iraqi Freedom and Operation Enduring Freedom: 2003-2004 versus 2006. J. Trauma 64, S21.
31. Kennedy, C.S., and Moffatt, M. (2004). Acute traumatic brain injury in children: exploring the cutting edge in understanding, therapy, and research. Clin. Pediatr. Emerg. Med. 5, 224-238.
32. Kiening, K.L., Hartl, R., Unterberg, A.W., Schneider, G.H., Bardt, T., and Lanksch, W.R. (1997). Brain tissue PO2 monitoring in comatose patients; implications for therapy. Neurol. Res. 19, 233-240. (Pubitemid 27251917)
33. Kirchhoff, C., Buhmann, S., Braunstein, V., Leidel, B.A., Vogel, T., Kreimeier, U., Mutschler, W., and Biberthaler, P. (2008). Cerebrospinal S100-B: a potential marker for progressive intracranial hemorrhage in patients with severe traumatic brain injury. Eur. J. Med. Res. 13, 511-516.
34. Korfias, S., Stranjalis, G., Boviatsis, E., Psachoulia, C., Jullien, G., Gregson, B., Mendelow, A.D., and Sakas, D.E. (2007). Serum S-100B protein monitoring in patients with severe traumatic brain injury. Intensive Care Med. 33, 255-260. (Pubitemid 46221230)
35. Kraus, J.F., McArthur, D.L., Silverman, T.A., and Jayaraman, M. (1996). Epidemiology of brain injury, in: Neurotrauma. R.K. Narayan, J.E. Wilberger, and J.T. Povlishock, (eds). McGraw- Hill: New York, pps. 13-30.
36. Langlois, J., Rutland-Brown W., and Wald, M. (2006). The epidemiology and impact of traumatic brain injury: a brief overview. J. Head Trauma Rehabil. 21, 375-378. (Pubitemid 44413110)
37. Lumpkins, K.M., Bochicchio, G.V., Keledjian, K., Simard, J.M., McCunn, M., and Scalea, T. (2008). Glial fibrillary acidic protein is highly correlated with brain injury. J. Trauma 65, 778-782.
38. Marangos, P.J., and Schmechel, D.E. (1987). Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Annu. Rev. Neurosci. 10, 269-295. (Pubitemid 17022775)
39. Marshall L.F., Marshall S.B., Klauber M.R., Van Berkum Clark M., Eisenberg H., Jane J.A., Luerssen T.G., Marmarou A., Foulkes M.A. The diagnosis of head injury requires a classification based on computed axial tomography J N.eurotrauma 1992.